Monday, October 26, 2026 · Daily editionET --:--:--

Finished

Coronary Stenting and Coronary Bypass Grafting at the Same Time in a Specialty Built Operating Room

NCT00366015 · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · Updated 28 Aug 2017

What is being tested
Robotic-assisted Coronary Surgical Revascularization; PCI- Drug Eluting Stents
For
Coronary Artery Disease
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 30 years to 85 years. About 80 people. The full rules are on the registry page.
Where
Canada
When
Starts or started 29 July 2003, ends 31 Dec 2010. Registered 18 Aug 2006.
Results
None posted yet.

In the researchers' words

This study will combine coronary stenting with minimally invasive robotic coronary bypass surgery, accomplished with the use of the da Vinci robot, to restore blood flow to occluded coronary arteries. Two previously approved and commonly performed procedures used to treat coronary artery disease(coronary stenting and robotic bypass surgery) are being combined into a hybrid surgery in a specialty built operating room. Patients with low risk coronary lesions will undergo cardiac hybrid revascularization using stenting and LIMA to LAD robotic bypass concomitantly. Patients' postoperative bleeding rates, angiographs and complication free rates will be recorded.
ClinicalTrials.gov, NCT00366015

Sites

  • The London Health Sciences Centre, University HospitalLondon, Ontario, Canada